JP2023545017A5 - - Google Patents
Info
- Publication number
- JP2023545017A5 JP2023545017A5 JP2023520341A JP2023520341A JP2023545017A5 JP 2023545017 A5 JP2023545017 A5 JP 2023545017A5 JP 2023520341 A JP2023520341 A JP 2023520341A JP 2023520341 A JP2023520341 A JP 2023520341A JP 2023545017 A5 JP2023545017 A5 JP 2023545017A5
- Authority
- JP
- Japan
- Prior art keywords
- sftpb
- cyfra21
- reporter molecule
- pro
- cea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063086865P | 2020-10-02 | 2020-10-02 | |
| US63/086,865 | 2020-10-02 | ||
| US202063106187P | 2020-10-27 | 2020-10-27 | |
| US63/106,187 | 2020-10-27 | ||
| PCT/US2021/052611 WO2022072471A1 (en) | 2020-10-02 | 2021-09-29 | Methods for the detection and treatment of lung cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023545017A JP2023545017A (ja) | 2023-10-26 |
| JP2023545017A5 true JP2023545017A5 (https=) | 2024-10-07 |
Family
ID=80950972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023520341A Pending JP2023545017A (ja) | 2020-10-02 | 2021-09-29 | 肺がんの検出及び治療のための方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240159753A1 (https=) |
| EP (1) | EP4222287A4 (https=) |
| JP (1) | JP2023545017A (https=) |
| KR (1) | KR20230080442A (https=) |
| CA (1) | CA3163498A1 (https=) |
| WO (1) | WO2022072471A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7311417B2 (ja) * | 2017-02-09 | 2023-07-19 | ボード オブ レジェンツ，ザ ユニバーシティ オブ テキサス システム | 肺癌の検出および処置のための方法 |
| AU2021213150A1 (en) | 2020-01-30 | 2022-08-04 | Prognomiq Inc | Lung biomarkers and methods of use thereof |
| WO2022212583A1 (en) | 2021-03-31 | 2022-10-06 | PrognomIQ, Inc. | Multi-omic assessment |
| GB2607436A (en) * | 2021-03-31 | 2022-12-07 | Prognomiq Inc | Multi-omic assessment |
| WO2023039479A1 (en) | 2021-09-10 | 2023-03-16 | PrognomIQ, Inc. | Direct classification of raw biomolecule measurement data |
| CN118215845A (zh) | 2021-09-13 | 2024-06-18 | 普罗科技有限公司 | 增强的对生物分子的检测和定量 |
| WO2024107923A1 (en) * | 2022-11-17 | 2024-05-23 | Board Of Regents, The University Of Texas System | Methods for the detection and treatment of lung cancer |
| WO2024249401A2 (en) * | 2023-05-31 | 2024-12-05 | Board Of Regents, The University Of Texas System | Methods for the detection and treatment of lung cancer |
| GB202310137D0 (en) * | 2023-07-03 | 2023-08-16 | Belgian Volition Srl | Method for the detection of cancer |
| WO2025064345A2 (en) * | 2023-09-22 | 2025-03-27 | Board Of Regents, The University Of Texas System | Methods for the detection and treatment of lung cancer |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1610127B1 (en) * | 2003-03-11 | 2012-04-25 | CRC Inc. | N1,n12-diacetylspermine as tumor marker |
| ES2553442T3 (es) * | 2006-01-05 | 2015-12-09 | The Ohio State University Research Foundation | Procedimientos basados en los microARN para el diagnóstico, pronóstico y tratamiento del cáncer de pulmón |
| SG186953A1 (en) * | 2010-07-09 | 2013-02-28 | Somalogic Inc | Lung cancer biomarkers and uses thereof |
| WO2013154998A1 (en) * | 2012-04-09 | 2013-10-17 | Duke University | Serum biomarkers and pulmonary nodule size for the early detection of lung cancer |
| US9753037B2 (en) * | 2013-03-15 | 2017-09-05 | Rush University Medical Center | Biomarker panel for detecting lung cancer |
| US11656229B2 (en) * | 2015-06-26 | 2023-05-23 | Biomark Cancer Systems Inc. | Method of detecting lung cancer |
| CN118522390A (zh) * | 2016-04-01 | 2024-08-20 | 20/20基因系统股份有限公司 | 帮助区别良性和恶性放射线照相明显肺结节的方法和组合物 |
| EP3361256A1 (en) * | 2017-02-08 | 2018-08-15 | Fundación para la Investigación Médica Aplicada | In vitro method for the diagnosis of lung cancer |
| JP7311417B2 (ja) * | 2017-02-09 | 2023-07-19 | ボード オブ レジェンツ，ザ ユニバーシティ オブ テキサス システム | 肺癌の検出および処置のための方法 |
-
2021
- 2021-09-29 EP EP21876378.7A patent/EP4222287A4/en active Pending
- 2021-09-29 KR KR1020237014384A patent/KR20230080442A/ko active Pending
- 2021-09-29 CA CA3163498A patent/CA3163498A1/en active Pending
- 2021-09-29 WO PCT/US2021/052611 patent/WO2022072471A1/en not_active Ceased
- 2021-09-29 JP JP2023520341A patent/JP2023545017A/ja active Pending
-
2023
- 2023-03-31 US US18/193,917 patent/US20240159753A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023545017A5 (https=) | ||
| US20240361322A1 (en) | Lung cancer biomarkers | |
| KR101788414B1 (ko) | 간암 조기 진단용 바이오마커 및 그 용도 | |
| TWI698639B (zh) | 前列腺抗原標準品及其用途 | |
| JP2020510816A5 (https=) | ||
| KR101520615B1 (ko) | 간암 진단용 바이오 마커 | |
| CA2792163A1 (en) | Biomarkers of osteoarthritis | |
| US20240027456A1 (en) | Lung cancer biomarkers | |
| US20240151726A1 (en) | Diagnostic methods for liver disorders | |
| US20230358764A1 (en) | Diagnostic methods for liver disorders | |
| CN113567687A (zh) | 检测样品中两种生物标志物的表达水平的试剂在制备用于检测子痫前期试剂盒中的应用 | |
| EP2784511A1 (en) | Integrin alpha-v-beta6 for diagnosis/prognosis of colorectal carcinoma | |
| JP7650538B2 (ja) | 血液由来エクソソームから見出した新規アルツハイマー病診断用バイオマーカー及びそれを用いたアルツハイマー病診断方法 | |
| US8053198B2 (en) | Diagnostic methods | |
| Choi et al. | Evaluation of revisited fucosylated alpha-fetoprotein (AFP-L3) with an autoanalyzer μTAS in a clinical laboratory | |
| KR20230113742A (ko) | 난소암의 검출 및 치료를 위한 방법 | |
| CN120210363A (zh) | 用于诊断晚期鼻咽癌的生物标志物及其应用 | |
| KR101144324B1 (ko) | 대장암 예후진단용 단백질 마커 디펜신?５와 ｒｏｄ１단백질의 조합 및 이들 각각에 대한 항체를 포함하는 대장암 예후진단키트 | |
| CN114814243B (zh) | 应用于蛋白质抗原的定量检测试剂盒及方法 | |
| CN109154612B (zh) | 生物样品中磷酸化和非磷化形式的rkip的定量评估方法 | |
| US20220299514A1 (en) | Biomarkers of therapeutic responsiveness | |
| KR101859812B1 (ko) | 간암 화학 색전술 치료 예후 예측을 위한 바이오마커 및 그 용도 | |
| WO2023230584A1 (en) | Methods and systems for risk stratification and management of bladder cancer | |
| CN113981092A (zh) | 用于预测肿瘤药物敏感性的生物标志物及其相关产品 | |
| US20250110132A1 (en) | Biomarkers for the determination of sample adequacy and lung cancer metastases |